These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27016400)

  • 1. Concise Review: Cellular Therapies: The Potential to Regenerate and Restore Tolerance in Immune-Mediated Intestinal Diseases.
    Ciccocioppo R; Cangemi GC; Kruzliak P; Corazza GR
    Stem Cells; 2016 Jun; 34(6):1474-86. PubMed ID: 27016400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cell therapy in intestinal diseases.
    Ciccocioppo R; Fioravante M; Frulloni L
    Curr Opin Organ Transplant; 2018 Dec; 23(6):679-689. PubMed ID: 30300331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating cell therapy for inflammatory bowel disease.
    Okamoto R; Watanabe M
    Expert Opin Biol Ther; 2016 Aug; 16(8):1015-23. PubMed ID: 27113391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.
    Ibraheim H; Giacomini C; Kassam Z; Dazzi F; Powell N
    Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):141-153. PubMed ID: 29096549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are stem cells a potential therapeutic tool in coeliac disease?
    Ciccocioppo R; Cangemi GC; Roselli EA; Kruzliak P
    Cell Mol Life Sci; 2015 Apr; 72(7):1317-29. PubMed ID: 25511197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell therapy in inflammatory bowel disease: which, when and how?
    van Deen WK; Oikonomopoulos A; Hommes DW
    Curr Opin Gastroenterol; 2013 Jul; 29(4):384-90. PubMed ID: 23666365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
    Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
    Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review.
    Voswinkel J; Francois S; Simon JM; Benderitter M; Gorin NC; Mohty M; Fouillard L; Chapel A
    Clin Rev Allergy Immunol; 2013 Oct; 45(2):180-92. PubMed ID: 23296948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of epithelial cells in the pathogenesis and treatment of inflammatory bowel disease.
    Okamoto R; Watanabe M
    J Gastroenterol; 2016 Jan; 51(1):11-21. PubMed ID: 26138071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated enteropathies: From bench to bedside.
    van Wanrooij RLJ; Bontkes HJ; Neefjes-Borst EA; Mulder CJ; Bouma G
    J Autoimmun; 2021 Mar; 118():102609. PubMed ID: 33607573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-activation of mesenchymal stem cells with TNF-α, IL-1β and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury.
    Chen H; Min XH; Wang QY; Leung FW; Shi L; Zhou Y; Yu T; Wang CM; An G; Sha WH; Chen QK
    Sci Rep; 2015 Mar; 5():8718. PubMed ID: 25732721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic enteropathy and feeding.
    Salvatore S; Hauser B; Vandenplas Y
    Nestle Nutr Workshop Ser Pediatr Program; 2007; 59():115-26; discussion 126-31. PubMed ID: 17245095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases.
    Al-toma A; Nijeboer P; Bouma G; Visser O; Mulder CJ
    World J Gastroenterol; 2014 Dec; 20(46):17368-75. PubMed ID: 25516648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course.
    Salem GA; Selby GB
    Stem Cell Investig; 2017; 4():95. PubMed ID: 29270421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of stem cells.
    Wada N; Gronthos S; Bartold PM
    Periodontol 2000; 2013 Oct; 63(1):198-216. PubMed ID: 23931061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular therapy of kidney diseases.
    Imai N; Kaur T; Rosenberg ME; Gupta S
    Semin Dial; 2009; 22(6):629-35. PubMed ID: 20017833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling.
    Rodríguez R; García-Castro J; Trigueros C; García Arranz M; Menéndez P
    Adv Exp Med Biol; 2012; 741():187-205. PubMed ID: 22457111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerogenic effect of mesenchymal stromal cells on gliadin-specific T lymphocytes in celiac disease.
    Ciccocioppo R; Camarca A; Cangemi GC; Radano G; Vitale S; Betti E; Ferrari D; Visai L; Strada E; Badulli C; Locatelli F; Klersy C; Gianfrani C; Corazza GR
    Cytotherapy; 2014 Aug; 16(8):1080-91. PubMed ID: 24831843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise Review: Stem Cell Trials Using Companion Animal Disease Models.
    Hoffman AM; Dow SW
    Stem Cells; 2016 Jul; 34(7):1709-29. PubMed ID: 27066769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.